Suivre
Bruno Zeitouni
Bruno Zeitouni
Bioinformatician
Adresse e-mail validée de oncotest.de
Titre
Citée par
Citée par
Année
SVDetect: a tool to identify genomic structural variations from paired-end and mate-pair sequencing data
B Zeitouni, V Boeva, I Janoueix-Lerosey, S Loeillet, P Legoix-Né, ...
Bioinformatics 26 (15), 1895-1896, 2010
2322010
Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial
N Servant, J Roméjon, P Gestraud, P La Rosa, G Lucotte, S Lair, ...
Frontiers in genetics 5, 152, 2014
852014
Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis
M Wassef, V Rodilla, A Teissandier, B Zeitouni, N Gruel, B Sadacca, ...
Genes & development 29 (24), 2547-2562, 2015
782015
Signalling Pathways Involved in Adult Heart Formation Revealed by Gene Expression Profiling in Drosophila
B Zeitouni, S Sénatore, D Séverac, C Aknin, M Sémériva, L Perrin
PLoS genetics 3 (10), e174, 2007
782007
Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model
J Tarabeux, B Zeitouni, V Moncoutier, H Tenreiro, K Abidallah, S Lair, ...
European Journal of Human Genetics 22 (4), 535-541, 2014
632014
Whole-exome somatic mutation analysis of mouse cancer models and implications for preclinical immunomodulatory drug development
B Zeitouni, C Tschuch, JM Davis, AL Peille, Y Raeva, M Landesfeind, ...
Cancer Research 77 (13_Supplement), 1840-1840, 2017
132017
Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma
AL Peille, V Vuaroqueaux, SS Wong, J Ting, K Klingner, B Zeitouni, ...
Communications biology 3 (1), 367, 2020
112020
Whole-exome sequencing analysis across 23 histotypes of patient-derived tumor xenografts reveals their similarities with TCGA patient tumors
F Foucault, F Kiefer, B Zeitouni, J Virayah, T Metcalfe, V Vuaroqueaux, ...
Cancer Research 74 (19_Supplement), 1203-1203, 2014
32014
Subtyping of pancreatic cancer patient-derived xenograft tumors and implications for anticancer agent testing
P Bronsert, T Kees, B Zeitouni, AL Peille, M Landesfeind, HH Fiebig, ...
Proceedings of the 107th Annual Meeting of the American Association for …, 2016
22016
A systematic patientderived xenograft based solution for preclinical biomarker discovery
B Zeitouni, AL Peille, Z Amalou, T Metz, HH Fiebig, V Vuaroqueaux
Proceedings of the AACR-NCI-EORTC International Conference: Molecular …, 2015
22015
Combining whole-exome and RNA-Seq data improves the quality of PDX mutation profiles
M Landesfeind, B Zeitouni, AL Peille, V Vuaroqueaux
Compendium 1, 6, 2016
12016
Abstract LB-314: Whole exome sequencing analyses of gastric cancers reveal two distinct genomic alteration patterns with implications in drug sensitivity
AL Peille, SS Wong, F Kiefer, B Zeitouni, A Maier, F Foucault, T Kees, ...
Cancer Research 74 (19_Supplement), LB-314-LB-314, 2014
12014
Author Correction: Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma
AL Peille, V Vuaroqueaux, SS Wong, J Ting, K Klingner, B Zeitouni, ...
Communications biology 3, 2020
2020
Molecular Characteristics of Patient-Derived Tumor Xenografts: Similarities to Patient Tumors and Relevance for Biomarker Discovery
V Vuaroqueaux, AL Peille, B Zeitouni, AM Eades-Perner, HH Fiebig
Patient-Derived Mouse Models of Cancer: Patient-Derived Orthotopic …, 2017
2017
The Charles River PDX Compendium: A database of well-characterized PDX models with molecular and drug sensitivity profiles for preclinical studies
B Zeitouni, M Landesfeind, AL Peille, M Weidner, P Bronsert, ...
European Journal of Cancer 1 (69), S59, 2016
2016
Abstract A102: Molecular profiling of a non-small cell lung PDX collection by whole exome sequencing and RNAseq revealed subtype specificities with therapeutic implications
AL Peille, B Zeitouni, V Fiebig, HH Fiebig, V Vuaroqueaux
Molecular Cancer Therapeutics 14 (12_Supplement_2), A102-A102, 2015
2015
Abstract A20: A systematic patient-derived xenograft based solution for pre-clinical biomarker discovery
B Zeitouni, AL Peille, Z Amalou, T Metz, HH Fiebig, V Vuaroqueaux
Molecular Cancer Therapeutics 14 (12_Supplement_2), A20-A20, 2015
2015
Abstract A101: Comprehensive genomic profile analyses of small cell lung cancer patient-derived xenografts for pharmacogenomics
V Vuaroqueaux, AL Peille, B Zeitouni, V Fiebig, HH Fiebig
Molecular Cancer Therapeutics 14 (12_Supplement_2), A101-A101, 2015
2015
Abstract B70: High-throughput analysis of 3D tumor colony formation of primary cell suspensions derived from xenografts to identify efficacy of anti-tumor agents in single …
A Maier, S Dhar, A Maunz, B Zeitouni, AL Peille, T Giesemann, HH Fiebig
Molecular Cancer Therapeutics 14 (12_Supplement_2), B70-B70, 2015
2015
Classification of colorectal PDX into transcriptomic subtypes associated with distinct genomic alteration profiles and in vivo response patterns to therapies
AL Peille, C Gredy, B Zeitouni, A Maier, K Klingner, T Kees, J Schüler, ...
Cancer Research 75 (15_Supplement), 1705-1705, 2015
2015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20